loading
Orthofix Medical Inc stock is traded at $12.11, with a volume of 568.61K. It is down -1.62% in the last 24 hours and down -17.73% over the past month. Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.
See More
Previous Close:
$12.31
Open:
$12.5
24h Volume:
568.61K
Relative Volume:
2.21
Market Cap:
$540.30M
Revenue:
$771.65M
Net Income/Loss:
$-120.49M
P/E Ratio:
-3.7962
EPS:
-3.19
Net Cash Flow:
$-73.76M
1W Performance:
-12.18%
1M Performance:
-17.73%
6M Performance:
-37.61%
1Y Performance:
-16.43%
1-Day Range:
Value
$12.07
$12.77
1-Week Range:
Value
$10.50
$13.68
52-Week Range:
Value
$10.50
$20.73

Orthofix Medical Inc Stock (OFIX) Company Profile

Name
Name
Orthofix Medical Inc
Name
Phone
214-937-2000
Name
Address
3451 PLANO PARKWAY, LEWISVILLE, TX
Name
Employee
1,616
Name
Twitter
@OrthofixUK
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
OFIX's Discussions on Twitter

Compare OFIX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
OFIX
Orthofix Medical Inc
12.11 540.30M 771.65M -120.49M -73.76M -3.19
Medical Devices icon
ABT
Abbott Laboratories
133.24 231.09B 42.34B 13.50B 6.66B 7.71
Medical Devices icon
BSX
Boston Scientific Corp
102.86 155.24B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
380.92 144.54B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
83.48 108.82B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
73.68 44.31B 5.54B 4.18B 623.10M 7.00

Orthofix Medical Inc Stock (OFIX) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-22-25 Initiated Canaccord Genuity Buy
Nov-08-24 Upgrade Stifel Hold → Buy
May-08-24 Upgrade ROTH MKM Neutral → Buy
Oct-20-23 Initiated ROTH MKM Neutral
Sep-12-23 Downgrade BTIG Research Buy → Neutral
Sep-12-23 Downgrade Stifel Buy → Hold
Jul-19-23 Resumed BTIG Research Buy
Mar-04-22 Upgrade Stifel Hold → Buy
Oct-20-20 Initiated Stifel Hold
Oct-29-19 Downgrade Cantor Fitzgerald Overweight → Neutral
Jun-01-18 Initiated Cantor Fitzgerald Overweight
Jun-21-17 Initiated BTIG Research Buy
Jun-14-17 Initiated Ladenburg Thalmann Buy
May-23-17 Initiated SunTrust Buy
Jul-10-15 Initiated Sidoti Buy
May-09-13 Downgrade Mizuho Buy → Neutral
Jan-08-13 Reiterated Mizuho Buy
Jun-21-10 Initiated Boenning & Scattergood Outperform
Mar-09-10 Reiterated Jefferies & Co Buy
Feb-18-10 Upgrade Susquehanna Financial Neutral → Positive
Jan-22-10 Initiated Jefferies & Co Buy
Nov-03-09 Upgrade Wells Fargo Underperform → Market Perform
Jul-31-09 Reiterated Jefferies & Co Buy
Jul-31-09 Upgrade Thomas Weisel Market Weight → Overweight
May-26-09 Reiterated Jefferies & Co Buy
Apr-17-09 Downgrade Wachovia Mkt Perform → Underperform
Feb-19-09 Initiated Canaccord Adams Buy
Jul-07-08 Downgrade Wachovia Outperform → Mkt Perform
View All

Orthofix Medical Inc Stock (OFIX) Latest News

pulisher
May 09, 2025

Bone Grafts and Substitutes Market to Reach $4.4 Billion by 2033, - openPR.com

May 09, 2025
pulisher
May 09, 2025

Lost Money on Orthofix Medical Inc.(OFIX)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire

May 09, 2025
pulisher
May 09, 2025

Class Action Filed Against Orthofix Medical Inc. (OFIX)October 21, 2024 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire

May 09, 2025
pulisher
May 08, 2025

Shareholders that lost money on Orthofix Medical Inc. (OFIX) should contact Levi & Korsinsky about pending Class ActionOFIX - ACCESS Newswire

May 08, 2025
pulisher
May 08, 2025

Orthofix targets $808M to $816M revenue in 2025 with key product launches - MSN

May 08, 2025
pulisher
May 08, 2025

Lost Money on Orthofix Medical Inc. (OFIX)? You May Have Been Affected by FraudContact Levi & Korsinsky - ACCESS Newswire

May 08, 2025
pulisher
May 08, 2025

Bone Regeneration Market Size, Share, Growth | 2025-2034 - Allied Market Research

May 08, 2025
pulisher
May 08, 2025

Stifel maintains Buy on Orthofix stock, reiterates $24 target By Investing.com - Investing.com Australia

May 08, 2025
pulisher
May 07, 2025

Institutional investors may adopt severe steps after Orthofix Medical Inc.'s (NASDAQ:OFIX) latest 15% drop adds to a year losses - simplywall.st

May 07, 2025
pulisher
May 07, 2025

Orthofix Medical Inc. (NASDAQ:OFIX) Q1 2025 Earnings Call Transcript - Insider Monkey

May 07, 2025
pulisher
May 07, 2025

Orthofix Q1 2025 net sales increase 3% to USD 193.6M - Medical Buyer

May 07, 2025
pulisher
May 07, 2025

Orthofix Medical Inc (OFIX) Q1 2025 Earnings Call Highlights: Strong Growth in Orthopedics and ... - Yahoo Finance

May 07, 2025
pulisher
May 07, 2025

Orthofix Medical Reports Q1 2025 Financial Growth - TipRanks

May 07, 2025
pulisher
May 06, 2025

Orthofix: Q1 Earnings Snapshot - Midland Daily News

May 06, 2025
pulisher
May 06, 2025

Stifel maintains Buy on Orthofix stock, reiterates $24 target - Investing.com

May 06, 2025
pulisher
May 06, 2025

Orthofix Medical Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:OFIX) - Seeking Alpha

May 06, 2025
pulisher
May 06, 2025

Earnings call transcript: Orthofix Q1 2025 misses EPS forecasts, shares fall - Investing.com

May 06, 2025
pulisher
May 06, 2025

Orthofix (OFIX) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 06, 2025
pulisher
May 06, 2025

OFIX Exceeds Q1 Revenue Expectations Amid Business Transformatio - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Orthofix (OFIX) Revises FY25 Sales Outlook and Confirms EBITDA G - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Orthofix (OFIX) Revises FY25 Sales Outlook and Confirms EBITDA Guidance | OFIX Stock News - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Orthofix Reports First Quarter 2025 Financial Results - BioSpace

May 06, 2025
pulisher
May 06, 2025

Orthofix Medical Inc (OFIX) Q1 Earnings: Revenue Surpasses Estimates at $193.6M, EPS Misses with $(1.35) Loss - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Orthofix Gains FDA Clearance for New Bone System - TipRanks

May 06, 2025
pulisher
May 06, 2025

Orthofix Q1 2025 slides: revenue grows 6% as EBITDA margins expand - Investing.com Australia

May 06, 2025
pulisher
May 06, 2025

Orthofix Q1 2025 slides: revenue grows 6% as EBITDA margins expand By Investing.com - Investing.com South Africa

May 06, 2025
pulisher
May 06, 2025

Orthofix Medical Inc. SEC 10-Q Report - TradingView

May 06, 2025
pulisher
May 06, 2025

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Orthofix Medical Inc. (OFIX) Shareholders - ACCESS Newswire

May 06, 2025
pulisher
May 05, 2025

Orthofix Medical Inc (OFIX) Q1 2025 Earnings Report Preview: What To Look For - Yahoo Finance

May 05, 2025
pulisher
Apr 29, 2025

Orthobiologics Market Growth Statistics & Future Prospects | Medtronic, Orthofix Medical, Bioventus - openPR.com

Apr 29, 2025
pulisher
Apr 28, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 28, 2025
pulisher
Apr 25, 2025

OFIX Investors Have Opportunity to Lead Orthofix Medical Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 18, 2025

Orthofix Medical CLO Sells Shares to Cover Tax Obligations - TradingView

Apr 18, 2025

Orthofix Medical Inc Stock (OFIX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Orthofix Medical Inc Stock (OFIX) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Cedron Jorge Andres
CLO
Apr 16 '25
Sale
13.31
3,816
50,791
42,500
Gillespie Geoffrey C
CAO
Apr 02 '25
Sale
15.74
76
1,196
42,445
Vitale Lucas
CP&BOO
Mar 18 '25
Sale
16.60
4,287
71,164
135,317
Gillespie Geoffrey C
CAO
Mar 18 '25
Sale
16.60
296
4,914
42,521
Calafiore Massimo
President & CEO
Mar 05 '25
Buy
17.43
9,914
172,801
222,404
Gillespie Geoffrey C
CAO
Feb 03 '25
Sale
17.79
767
13,645
39,323
Gillespie Geoffrey C
CAO
Feb 04 '25
Sale
18.08
187
3,381
39,136
Andrews Julie
CFO
Jan 16 '25
Sale
17.89
4,655
83,278
28,312
Calafiore Massimo
President & CEO
Jan 10 '25
Sale
16.83
10,078
169,619
133,354
Calafiore Massimo
President & CEO
Jan 13 '25
Sale
17.14
9,203
157,757
124,151
medical_devices ZBH
$95.21
price up icon 0.11%
medical_devices STE
$226.43
price up icon 0.25%
medical_devices PHG
$24.54
price up icon 1.95%
$84.67
price down icon 0.79%
$69.87
price down icon 0.89%
medical_devices EW
$73.68
price down icon 1.27%
Cap:     |  Volume (24h):